Flow cytometry showed that the inhibition of AP-2α expression effectively inhibited the POSTN-induced increase in the numbers of CD133+ cells, while AP-2α overexpression increased the numbers of CD133+ HCC cells (Fig. 4C). The gene discussed is PROM1; the disease is hepatocellular carcinoma.